Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix, Covance, Expression Analysis, US Food and Drug Administration

Premium

Affymetrix last week released its GeneChip Blood RNA Concentration Kit. The kit is intended for use with methods that isolate RNA from unfractionated human whole blood only, such as the PAXgene Blood RNA System from PreAnalytiX.

The Blood RNA Concentration Kit provides reagents to concentrate purified blood RNA to a volume suitable for target preparation


Covance and Expression Analysis last week co-launched a genomics testing service for pharmaceutical and biotechnology firms. Expression Analysis will now provide Covance's Central Laboratory Services unit with the tools to conduct genomic microarray testing as part of their offered clinical trial services.

The offering comes a week after the US Food and Drug Administration released a pharmacogenomics guidance that indicates that genomic data submission may be become a regular component in the drug-discovery process.

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.